Clinical trial
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY…
NCT00474487 · Novartis Vaccines, Industry · Completed
Key facts
| NCT number | NCT00474487 |
|---|---|
| Title | A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults |
| Official title | A Phase 3, Multi-center Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adults and Compare to the Safety and Immune Response of a Licensed Conjugate Meningococcal ACWY Vaccine in Subjects Aged 19-55 Years of Age and to a Licensed Polysaccharide… |
| Lead sponsor | Novartis Vaccines, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Meningococcal Meningitis, Meningococcal Infections |
| Intervention type | Biological |
| Interventions | Meningococcal ACWY Polysaccharide Vaccine, MenACWY CRM (19 to 55 years), Meningococcal ACWY Conjugate Vaccine, Novartis MenACWY Vaccine (56 to 65 Years) |
| Enrollment | 2,831 |
| Start date | May 1, 2007 |
| Primary completion | Aug 1, 2007 |
| Completion | Feb 1, 2008 |
| First posted | May 17, 2007 |
| Last update posted | Apr 21, 2014 |
| Countries | Argentina, Colombia |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: